Literature DB >> 2687293

Expression of the fgr protooncogene product as a function of myelomonocytic cell maturation.

V Notario1, J S Gutkind, M Imaizumi, S Katamine, K C Robbins.   

Abstract

The fgr protooncogene is a member of the src family of protein tyrosine kinases. Recent studies have shown that normal myelomonocytic cells and tissue macrophages are the major sites of fgr mRNA expression. In the present study, we have identified the fgr protooncogene protein product in HL60 cells and have examined its expression as a function of HL60 cell maturation. Whether induced toward monocytic or granulocytic lineages, p55c-fgr accumulated in HL60 cells during maturation. In differentiated cells, the protein was active as a protein tyrosine kinase and was localized to peripheral cell membranes. Demonstration that a myristyl group was covalently bound to the protein probably accounted for its subcellular distribution. These findings establish developmental regulation of p55c-fgr in a lineage that represents its natural site of expression.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2687293      PMCID: PMC2115966          DOI: 10.1083/jcb.109.6.3129

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  34 in total

1.  Characterization of cDNA clones for the human c-yes gene.

Authors:  J Sukegawa; K Semba; Y Yamanashi; M Nishizawa; N Miyajima; T Yamamoto; K Toyoshima
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

2.  Differentiation of myeloid cells is accompanied by increased levels of pp60c-src protein and kinase activity.

Authors:  C E Gee; J Griffin; L Sastre; L J Miller; T A Springer; H Piwnica-Worms; T M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 3.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 4.  The granulocyte-macrophage colony-stimulating factors.

Authors:  D Metcalf
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

5.  Expression of the c-fms proto-oncogene during human monocytic differentiation.

Authors:  E Sariban; T Mitchell; D Kufe
Journal:  Nature       Date:  1985 Jul 4-10       Impact factor: 49.962

6.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.

Authors:  C J Sherr; C W Rettenmier; R Sacca; M F Roussel; A T Look; E R Stanley
Journal:  Cell       Date:  1985-07       Impact factor: 41.582

7.  Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog.

Authors:  J E Buss; B M Sefton
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

8.  Isolation and chromosomal localization of the human fgr protooncogene, a distinct member of the tyrosine kinase gene family.

Authors:  S R Tronick; N C Popescu; M S Cheah; D C Swan; S C Amsbaugh; C R Lengel; J A DiPaolo; K C Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Effects of two major activating lesions on the structure and conformation of human ras oncogene products.

Authors:  S K Srivastava; Y Yuasa; S H Reynolds; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

10.  Activation of the pp60c-src kinase during differentiation of monomyelocytic cells in vitro.

Authors:  A Barnekow; M Gessler
Journal:  EMBO J       Date:  1986-04       Impact factor: 11.598

View more
  13 in total

1.  Lipopeptides are effective stimulators of tyrosine phosphorylation in human myeloid cells.

Authors:  S Offermanns; R Seifert; J W Metzger; G Jung; A Lieberknecht; U Schmidt; G Schultz
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

Review 2.  Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis.

Authors:  Daniel E Johnson
Journal:  Adv Enzyme Regul       Date:  2007-11-19

3.  Association of immunoglobulin G Fc receptor II with Src-like protein-tyrosine kinase Fgr in neutrophils.

Authors:  F Hamada; M Aoki; T Akiyama; K Toyoshima
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

4.  Src family kinase inhibitor bosutinib enhances retinoic acid-induced differentiation of HL-60 leukemia cells.

Authors:  Robert J MacDonald; Rodica P Bunaciu; Victoria Ip; David Dai; David Tran; Jeffrey D Varner; Andrew Yen
Journal:  Leuk Lymphoma       Date:  2018-03-23

5.  The role of the Fgr tyrosine kinase in the control of the adhesive properties of U937 monoblastoid cells and their derivatives.

Authors:  L Faulkner; M Patel; P M Brickell; D R Katz
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

6.  ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary.

Authors:  Johanna Congleton; Hong Jiang; Fabio Malavasi; Hening Lin; Andrew Yen
Journal:  Exp Cell Res       Date:  2010-12-13       Impact factor: 3.905

7.  Specific expression of human c-fgr in natural immunity effector cells.

Authors:  K Inoue; T Yamamoto; K Toyoshima
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

8.  A novel c-fgr exon utilized in Epstein-Barr virus-infected B lymphocytes but not in normal monocytes.

Authors:  J S Gutkind; D C Link; S Katamine; P Lacal; T Miki; T J Ley; K C Robbins
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

9.  Human c-fgr induces a monocyte-specific enzyme in NIH 3T3 cells.

Authors:  K Inoue; B Wongsasant; T Akiyama; K Toyoshima
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

10.  Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.

Authors:  J Congleton; R MacDonald; A Yen
Journal:  Leukemia       Date:  2011-12-19       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.